Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 October 2008

Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review

Aldona Anna Kasprzak, Karolina Anna Olejniczak

Med Sci Monit 2008; 14(10): RA179-189 :: ID: 869403


Interleukin 2 (IL-2), or T-cell growth factor (TCGF), represents the first identified, fully-characterized, purified human interleukin. It is produced mainly by T helper (CD4+) lymphocytes, stimulates cell-mediated immune responses, controls growth and differentiation of B lymphocytes, and intensifies proliferation and activity of all cytotoxic cell clones. IL-2 is a growth factor in vitro and a mediator of self-tolerance in vivo, and therefore interests tumor immunotherapy investigators. The role of IL-2 in the cell cycle of neoplastic cells remains unclear. IL-2 inhibits growth of certain human tumor cells while proliferation of other cells remains intact or is even stimulated. Decreased IL-2 production is often observed in the more advanced clinical stages of human tumors, which provides rational for inclusion of recombinant IL-2 in the immunotherapy for some tumors. On the other hand, tumor cells themselves may produce IL-2 and promote tumor growth. This article summarizes the current physiological role of IL-2 and its role in the pathogenesis of select human diseases. Many papers (including reviews) pertain to the IL-2R receptor. The soluble form of the alpha subunit of the IL-2 receptor (sIL-2Ralpha) is elevated in most proliferative disturbances of the hematopoietic system and in many solid tumors. Special reference to the most important discoveries and our own experience in intracellular detection of IL-2 and IL-2Ralpha are included. IL-2 properties, cellular sources, and targets, including data on its expression in pathological conditions, continue to be supplemented. Attempts to treat tumors are also discussed, using modified varieties of therapy that use IL-2 itself and/or its receptor.

Keywords: Protein Subunits - metabolism, Receptors, Interleukin-2 - metabolism, Neoplasms - immunology, Interleukin-2 - metabolism, Immune System Diseases - immunology, Signal Transduction - physiology

Add Comment 0 Comments


01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600


In Press

04 Mar 2024 : Clinical Research  

Injury-Admission Time is an Independent Risk Factor for Deep Vein Thrombosis in Older Patients with Osteopo...

Med Sci Monit In Press; DOI: 10.12659/MSM.943587  


04 Mar 2024 : Clinical Research  

Evaluation of the Interrater Reliability of Sonographic Measurements of Muscle Thickness of 38 Piriformis M...

Med Sci Monit In Press; DOI: 10.12659/MSM.943720  


05 Apr 2024 : Clinical Research  

Comparative Analysis of Transoral Endoscopic Parathyroidectomy Vestibular Approach and Focused Open Surgery...

Med Sci Monit In Press; DOI: 10.12659/MSM.944128  

05 Mar 2024 : Clinical Research  

Muscular Function Recovery from General Anesthesia in 132 Patients Undergoing Surgery with Acceleromyograph...

Med Sci Monit In Press; DOI: 10.12659/MSM.942780  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750